Roth Capital reiterated coverage on G1 Therapeutics with a new price target

9/1/21 8:29:49 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Roth Capital reiterated coverage of G1 Therapeutics with a rating of Buy and set a new price target of $56.00 from $57.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GTHX

Date	Price Target	Rating	Analyst
1/30/2023	$7.00 → $10.00	Underweight → Neutral	JP Morgan
1/3/2023	$32.00 → $31.00	Buy	Needham
11/4/2021	$20.00 → $19.00	Neutral → Underweight	JP Morgan
11/4/2021	$78.00 → $71.00	Buy	HC Wainwright & Co.
11/4/2021	$41.00 → $24.00	Outperform	Raymond James
10/15/2021	$51.00	Buy	BTIG Research
9/30/2021	$24.00 → $20.00	Overweight → Neutral	JP Morgan
9/1/2021	$57.00 → $56.00	Buy	Roth Capital